Circulation March 4, 2025 Issue

This week please join author Yugo Yamashita and Associate Editor
Joshua Beckman as they discuss the article "Rivaroxaban for 18
Months Versus 6 Months in Patients With Cancer and Acute Low-Risk
Pulmonary Embolism: An Open-Label, Multicenter, Randomized
Clinical Trial (ONCO PE Trial)."


For the episode transcript, visit:
https://www.ahajournals.org/do/10.1161/podcast.20250303.648421